Concepedia

Michael Böettcher

MB

10

Publications

310

Citations

10

H-Index

2010

Active since

Affiliations

Bayer (Germany)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

SocraTec R&D (Germany)

Städtisches Klinikum Dessau

University Hospital Bonn

Michael Böettcher is an author at Bayer (Germany) specializing in mitophagy, health sciences, and oxidative stress.

ORCID

Top concepts

Publications per year

2010–2022

10

Publications

10

Safety, pharmacodynamic, and pharmacokinetic characterization of vericiguat: results from six phase I studies in healthy subjects

Michael Böettcher, Dirk Thomas, Wolfgang Mueck et al. · European Journal of Clinical Pharmacology · 2020 · 68 citations · Full text

Metabolism and Pharmacokinetic Drug–Drug Interaction Profile of Vericiguat, A Soluble Guanylate Cyclase Stimulator: Results From Preclinical and Phase I Healthy Volunteer Studies

Michael Böettcher, Michael Gerisch, Maximilian T. Lobmeyer et al. · Clinical Pharmacokinetics · 2020 · 55 citations · Full text

Buprenorphine–cannabis interaction in patients undergoing opioid maintenance therapy

C Vierke, Brigitte Marxen, Michael Böettcher et al. · European Archives of Psychiatry and Clinical Neuroscience · 2020 · 34 citations · Full text

A validated workflow for drug detection in oral fluid by non-targeted liquid chromatography-tandem mass spectrometry

Vera Reinstadler, Stefan Lierheimer, Michael Böettcher et al. · Analytical and Bioanalytical Chemistry · 2018 · 33 citations · Full text

Repinotan, a Selective 5-HT1A-R-Agonist, Antagonizes Morphine-Induced Ventilatory Depression in Anesthetized Rats

Ulf Guenther, Hermann Wrigge, Nils Theuerkauf et al. · Anesthesia & Analgesia · 2010 · 28 citations

Rows per page

1–5 of 10